-
Loading metrics
Open Access
Peer-reviewed
Research Article
Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors
-
Susanne H. Sheehy ,
* E-mail: susanne.sheehy@ndm.ox.ac.uk
Affiliation Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom
⨯ -
Christopher J. A. Duncan,
Affiliation Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom
⨯ -
Sean C. Elias,
Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom
⨯ -
Sumi Biswas,
Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom
⨯ -
Katharine A. Collins,
Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom
⨯ -
Geraldine A. O'Hara,
Affiliation Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom
⨯ -
Fenella D. Halstead,
Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom
⨯ -
Katie J. Ewer,
Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom
⨯ -
Tabitha Mahungu,
Affiliation University College London Clinical Research Facility, University College Hospital, London, United Kingdom
⨯ -
Alexandra J. Spencer,
Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom
⨯ -
Kazutoyo Miura,
Affiliation Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America
⨯ -
Ian D. Poulton,
Affiliation Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom
⨯ -
Matthew D. J. Dicks,
Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom
⨯ -
Nick J. Edwards,
Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom
⨯ -
Eleanor Berrie,
Affiliation Clinical Biomanufacturing Facility, University of Oxford, Churchill Hospital, Oxford, United Kingdom
⨯ -
Sarah Moyle,
Affiliation Clinical Biomanufacturing Facility, University of Oxford, Churchill Hospital, Oxford, United Kingdom
⨯ -
Stefano Colloca,
Affiliation Okairòs AG, Rome, Italy
⨯ -
Riccardo Cortese,
Affiliations Okairòs AG, Rome, Italy, CEINGE, Naples, Italy
⨯ -
Katherine Gantlett,
Affiliation Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom
⨯ -
Carole A. Long,
Affiliation Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America
⨯ -
Alison M. Lawrie,
Affiliation Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom
⨯ -
Sarah C. Gilbert,
Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom
⨯ -
Tom Doherty,
Affiliation University College London Clinical Research Facility, University College Hospital, London, United Kingdom
⨯ -
Alfredo Nicosia,
Affiliations Okairòs AG, Rome, Italy, CEINGE, Naples, Italy
⨯ -
Adrian V. S. Hill,
Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom
⨯ - [ ... ],
-
Simon J. Draper
Affiliation The Jenner Institute, University of Oxford, Oxford, United Kingdom
⨯ - [ view all ]
- [ view less ]
Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors
- Susanne H. Sheehy,
- Christopher J. A. Duncan,
- Sean C. Elias,
- Sumi Biswas,
- Katharine A. Collins,
- Geraldine A. O'Hara,
- Fenella D. Halstead,
- Katie J. Ewer,
- Tabitha Mahungu,
- Alexandra J. Spencer
- Published: February 21, 2012
- https://doi.org/10.1371/journal.pone.0031208